GNF recently hosted approximately 250 internal and external attendees at the 2017 Technology Showcase focusing on novel approaches in cancer therapeutics. The clinical landscape for cancer is undergoing a fundamental shift as the arsenal of available medicines has expanded beyond chemotherapy to a host of new molecularly targeted therapies. These novel approaches exponentially improve our diagnostic and therapeutic abilities.
Investigators from GNF and the Salk Institute shared their vision for the future of cancer therapeutics and methodology to achieve new discoveries. With attendees from the diverse scientific and biotech community of San Diego, the event was highly collaborative with opportunities to share ideas and build relationships.